Jerry K. Benites-Meza, P. Herrera-Añazco, Arón A Santillán-Rodríguez, Carlos J. Zumarán-Nuñez, Luz C. Barturén-Alvarado, Vicente A Benites Zapata
{"title":"Association between self-medication with antibiotics and purchase of brand-name drugs: analysis of a national survey in Peru","authors":"Jerry K. Benites-Meza, P. Herrera-Añazco, Arón A Santillán-Rodríguez, Carlos J. Zumarán-Nuñez, Luz C. Barturén-Alvarado, Vicente A Benites Zapata","doi":"10.1093/jphsr/rmad015","DOIUrl":null,"url":null,"abstract":"\n \n \n To determine the association between self-medication with antibiotics (SMA) and purchase of brand-name drugs in Peru.\n \n \n \n A secondary analysis was conducted using a nationally representative survey from 2014 to 2016. The exposure variable was self-medication (SM), which is defined as the purchase of drugs for self-administration without a medical prescription. The study outcome was the purchase of brand-name drugs (yes/no). Sociodemographic variables, such as health insurance and type of institution, were considered as confounders. To assess the association between SMA and the purchase of brand-name drugs, the crude prevalence ratios (cPR) and adjusted prevalence ratios (aPR) were calculated with their confidence intervals at 95% (95% CI) using a Poisson-type generalized linear model and considering the complex survey design.\n \n \n \n A total of 1862 participants were analysed; 54.4% of the participants were women with a mean age of 39.3 years. The prevalence rate of SMA was 54.3%, whereas that of the purchase of brand-name drugs was 55.3%. The adjusted Poisson regression analysis showed an association between SMA and the purchase of brand-name drugs (aPR = 1.28; 95% CI: 1.18–1.37; P < 0.001).\n \n \n \n It was found that 5 of 10 respondents SMA. Approximately 6 of 10 respondents that SMA used brand-name drugs. SMA is associated with a higher probability of purchasing brand-name drugs.\n","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2023-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Health Services Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jphsr/rmad015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
To determine the association between self-medication with antibiotics (SMA) and purchase of brand-name drugs in Peru.
A secondary analysis was conducted using a nationally representative survey from 2014 to 2016. The exposure variable was self-medication (SM), which is defined as the purchase of drugs for self-administration without a medical prescription. The study outcome was the purchase of brand-name drugs (yes/no). Sociodemographic variables, such as health insurance and type of institution, were considered as confounders. To assess the association between SMA and the purchase of brand-name drugs, the crude prevalence ratios (cPR) and adjusted prevalence ratios (aPR) were calculated with their confidence intervals at 95% (95% CI) using a Poisson-type generalized linear model and considering the complex survey design.
A total of 1862 participants were analysed; 54.4% of the participants were women with a mean age of 39.3 years. The prevalence rate of SMA was 54.3%, whereas that of the purchase of brand-name drugs was 55.3%. The adjusted Poisson regression analysis showed an association between SMA and the purchase of brand-name drugs (aPR = 1.28; 95% CI: 1.18–1.37; P < 0.001).
It was found that 5 of 10 respondents SMA. Approximately 6 of 10 respondents that SMA used brand-name drugs. SMA is associated with a higher probability of purchasing brand-name drugs.